Brought to you by 
Bardy Diagnostics closes $35.5mm Series B
23 Apr 2019
Executive Summary
Bardy Diagnostics Inc. (ambulatory cardiac monitoring) raised $35.5mm in its Series B financing led by River Cities Capital Funds, which was joined by first-time backers HealthQuest Capital, Aperture Venture Partners, Aphelion Capital, Lumira Ventures, and Rex Health Ventures, and returning investors SV Health Investors, Health Enterprise Partners, and Ascension Ventures.
Deal Industry
- Medical Devices
-
Medical Devices
- Monitoring Equipment & Devices
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Bardy Diagnostics closes $35.5mm Series B
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice